Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5
MONTREAL, Sept. 30, 2020 – Theratechnologies (THTX), a biopharmaceutical company, has announced that Dr. Christian Marsolais, the Senior Vice President and Chief Medical Officer, will be presenting at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MONTREAL, Sept. 30, 2020 – Theratechnologies (THTX), a biopharmaceutical company, has announced that Dr. Christian Marsolais, the Senior Vice President and Chief Medical Officer, will be presenting at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5, 2020, at 4:30 p.m. ET. Investors and others interested can access a live webcast of the presentation through the provided link, with a replay available one hour post-event.
Theratechnologies specializes in innovative therapies that address unmet medical needs, with further information available on their official website.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +2.71%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer, will present at the H.C. Wainwright 4th Annual NASH Investor Conference on Monday, October 5, 2020 at 4:30 p.m. ET.
A live webcast of his presentation will be accessible at https://journey.ct.events/view/2ae02d3e-4e70-4522-bbba-b3fdb9b57e35. A replay of the webcast will be available one hour after the conclusion of the live event.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.